• New Launches

Eisai’s Fycompa for Adjunctive Treatment of Partial Onset Seizures Launched in China

New Delhi, January 07, 2019: Eisai Co., Ltd. has launched the in-house discovered and developed antiepileptic drug (AED) Fycompa, (generic…

Eisai’s Supplementary New Drug Application Submitted In Japan for Fycompa

As Monotherapy for Partial-Onset Seizures, Pediatric Indication for Partial-Onset Seizures, as Well as New Formulation Tokyo, February 03, 2019: Eisai Co., Ltd.…

Eisai’s New Drug Application for Perampanel Designated for Priority Review by China National Medical Products Administration

For Adjunctive Treatment of Partial Onset Seizures Tokyo, January 05, 2019: Eisai Co., Ltd. announced that its in-house discovered and…